rosacea
DESCRIPTION
Rosacea, Acne Rosacea, erythematotelangiectatic, papulopustular. phymatous, ocular rosaceaTRANSCRIPT
![Page 1: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/1.jpg)
ROSACEA(ACNE ROSACEA)
![Page 2: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/2.jpg)
![Page 3: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/3.jpg)
![Page 4: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/4.jpg)
WHAT IS ROSACEA?CHRONIC RELAPSING DISORDER WITH CHRONIC RELAPSING DISORDER WITH VARIABLE DEGRESS OF…..VARIABLE DEGRESS OF…..
•Persistent centrofacial erythema
•Telangiectasias
•Inflammatory papules
•Inflammatory pustules
•Nodules
•Edematous plaques (non-pitting)
•Ocular inflammation
•Phymatous changes
![Page 5: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/5.jpg)
ROSACEA
• Onset during middle age, with women being affected somewhat earlier than men.
• Rosacea occurs most frequently in Caucasians and in those with fair sun-sensitive skin, i.e. skin phototypes I and II.
• There may be a genetic predisposition to the disorder, as 10–20% of patients report a family history of rosacea.
![Page 6: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/6.jpg)
CLINICAL PICTURE OF ROSACEA
![Page 7: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/7.jpg)
SYMPTOMS OF ROSACEA
• ITCHY RASH ON FACE
• “STINGS”
• “BURNS”
• TOPICAL CREAMS NOT HELPFUL
• NO NEW MEDS
• NO NEW SOAPS OR PERFUMES
![Page 8: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/8.jpg)
• In 2002, a consensus publication provided a classification scheme for rosacea into four major forms with distinct clinical characteristics.
• Each subtype is graded into mild, moderate and severe (grades 1–3).
![Page 9: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/9.jpg)
![Page 10: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/10.jpg)
CLASSIFICATION OF ROSACEASubtypeSubtype Predominant clinical featuresPredominant clinical features
Erythemato-Erythemato-telangiectatictelangiectatic
1.1. Persistent centrofacial erythemaPersistent centrofacial erythema2.2. FlushingFlushing3.3. TelangiectasiasTelangiectasias4.4. Skin sensitivitySkin sensitivity
PapulopustularPapulopustular1.1. Persistent centrofacial erythemaPersistent centrofacial erythema2.2. PapulesPapules3.3. Pustules/papulopustulesPustules/papulopustules4.4. Overlap with other subtypes may occurOverlap with other subtypes may occur
PhymatousPhymatous
1.1. Thickened, nodular skin Thickened, nodular skin 2.2. Prominent poresProminent pores3.3. Can affect nose (rhinophyma), chin (gnathophyma), Can affect nose (rhinophyma), chin (gnathophyma),
forehead (metophyma), ears (otophyma), eyelids forehead (metophyma), ears (otophyma), eyelids (blepharophyma)(blepharophyma)
4.4. May be associated with other features of rosacea or May be associated with other features of rosacea or occur in isolationoccur in isolation
OcularOcular1.1. Dry, gritty sensation, pain or photophobiaDry, gritty sensation, pain or photophobia2.2. Blepharitis & ConjunctivitisBlepharitis & Conjunctivitis3.3. Chalazia and hordeolaChalazia and hordeola4.4. Keratitis, episcleritis, scleritis, uveitis (rare)Keratitis, episcleritis, scleritis, uveitis (rare)
![Page 11: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/11.jpg)
1. ERYTHEMATOTELANGIECTATIC ROSACEA
Patients typically have skin phototypes I or II
![Page 12: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/12.jpg)
Severity of Erythematotelangiectatic rosacea
![Page 13: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/13.jpg)
Erythematotelangiectatic rosacea. Persistent erythema of the medial and lateral
cheeks is seen. In this patient, there are no telangiectasias, indicating mild (grade 1) disease.
![Page 14: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/14.jpg)
Telangiectasias
![Page 15: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/15.jpg)
Telangiectasias become progressively
prominent, forming sprays on the nose,
nasolabial folds, cheeks and glabella
![Page 16: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/16.jpg)
2. PAPULOPUSTULAR ROSACEA
• C/O: C/O: slight tenderness or itch but social distress caused by the appearance of the eruption far exceeds the physical symptoms.
• C/F:C/F: Centrofacial eruption of multiple, small (<3 mm), dome-shaped, erythematous papules, some of which are surmounted by a seropustule can appear singly or in crops.
• Individual lesions last about 2 weeks then subside into a blotchy erythema, which gradually fades & others appear.
• Usually no resultant scarring.
![Page 17: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/17.jpg)
Severity of papulopustular rosacea
![Page 18: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/18.jpg)
Mild papulopustular rosacea
![Page 19: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/19.jpg)
Moderate papulopustular rosacea of the forehead. Note the superficial nature of the
inflammatory lesions.
![Page 20: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/20.jpg)
![Page 21: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/21.jpg)
Moderate to severe papulopustular rosacea.
There is a typical centrofacial distribution. In addition, the skin has a scaly, crusty surface and
this is often a sign of more severe disease.
![Page 22: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/22.jpg)
Severe papulopustular rosacea
Dense erythema, Papules, pustules,
nodules.Telangiectasias severe, diffuse. Variable
plaque-like edema
![Page 23: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/23.jpg)
3. PHYMATOUS ROSACEA • Most commonly rhinophyma
• Occurs primarily in men.
• Reflects hypertrophy of the sebaceous glands & connective tissue in nasal skin.
• May occur with sever rosacea, but surprisingly, patients with rhinophyma may only have mild rosacea.
• Rhinophyma is usually seen in patients with other features of rosacea but may occur in patients with acne vulgaris; occasionally it is due to chronic actinic damage or may arise de novo.
![Page 24: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/24.jpg)
![Page 25: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/25.jpg)
![Page 26: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/26.jpg)
Severity of phymatous rosacea
![Page 27: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/27.jpg)
The earliest clinical sign of rhinophyma is the appearance of dilated pores (patulous follicles)
on the distal portions of the nose
![Page 28: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/28.jpg)
RHINOPHYMA – EARLYTelangiectatic vessels of the distal nose may
predispose to subsequent development of hypertrophic changes of rhinophyma
![Page 29: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/29.jpg)
![Page 30: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/30.jpg)
RHINOPHYMAMODERATE
![Page 31: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/31.jpg)
SEVERE RHINOPHYMAHypertrophy of tissue with nasal distortion as soft, fleshy, nodular growths increase in size.
![Page 32: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/32.jpg)
4. OCULAR ROSACEA
• Can occur without accompanying cutaneous changes or it may be seen in patients with any of the other subtypes of rosacea.
• C/OC/O: nonspecific; itching, tearing, dryness, gritty sensations, crusting of eyelids & an inability to wear contact lenses, as well as frequent styes.
![Page 33: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/33.jpg)
Severity of ocular rosacea
![Page 34: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/34.jpg)
OCULAR ROSACEAOCULAR ROSACEA
There may be tiny concretions at the bases of the cilia (conical dandruff), or mild scaling of the
eyelid margins (scurf).
![Page 35: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/35.jpg)
Hordeolum
![Page 36: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/36.jpg)
![Page 37: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/37.jpg)
Common, may be first sign of rosaceavariable presentation
![Page 38: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/38.jpg)
4. OCULAR ROSACEA
• May need ophthalmological consultation especially (grade 3) disease
• Keratitis may lead to blindness
![Page 39: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/39.jpg)
VARIANTS OF ROSACEA1. GRANULOMATOUS ROSACEA:
Persistent red–brown to skin-colored facial papules with a characteristic non-caseating granulomatous histology.
2. ROSACEA CONGLOBATA: inflammatory facial cysts with associated scarring.
3. ROSACEA FULMINANS (pyoderma faciale): characterized by explosive onset of inflammatory papules and pustules superimposed on a back-ground of facial erythema & fever may occur.
![Page 40: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/40.jpg)
PATHOGENESIS OF ROSACEA
![Page 41: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/41.jpg)
WHAT CAUSES ROSACEA?
• The exact cause is unknown.• May be; • Demodex mite infestation?• Solar damage? Heat? Caffiene?• Lymphatic obstruction? Emotional stress?
![Page 42: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/42.jpg)
TRIGGERS OF ROSACEA
1.1. Sun exposure 81%Sun exposure 81%2.2. Emotional stress 79%Emotional stress 79%3.3. Hot weather 75%Hot weather 75%4.4. Wind 57%Wind 57%5.5. Heavy exercise 56%Heavy exercise 56%6.6. Alcohol consumption Alcohol consumption
52%52%7.7. Hot baths 51%Hot baths 51%8.8. Cold weather 46%Cold weather 46%9.9. Spicy foods 45%Spicy foods 45%10.10.Humidity 44%Humidity 44%11.11.Indoor heat 41%Indoor heat 41%
12.12. Certain skin-care Certain skin-care products 41%products 41%
13.13. Heated beverages 36%Heated beverages 36%14.14. Certain cosmetics 27%Certain cosmetics 27%15.15. Medications(specificallMedications(specificall
yy stimulants) 15%stimulants) 15%16.16. Medical conditions Medical conditions
15%15%17.17. Certain fruits 13%Certain fruits 13%18.18. Marinated meats 10%Marinated meats 10%19.19. Certain vegetables 9%Certain vegetables 9%20.20. Dairy products 8%Dairy products 8%
![Page 43: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/43.jpg)
![Page 44: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/44.jpg)
• H. pylori
![Page 45: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/45.jpg)
Demodex Found within follicular infundibula & sebaceous ducts…
![Page 46: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/46.jpg)
Commensal organisms….
![Page 47: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/47.jpg)
![Page 48: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/48.jpg)
![Page 49: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/49.jpg)
![Page 50: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/50.jpg)
![Page 51: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/51.jpg)
Edematous papules of Demodex folliculitis
(demodicidosis) superimposed upon the
characteristic background erythema .
![Page 52: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/52.jpg)
Microscopic findings of follicular contents obtained via scraping
of Demodex folliculitis.
![Page 53: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/53.jpg)
HISTOPATHOLOGY OF ROSACEA
![Page 54: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/54.jpg)
Erythematotelangiectatic rosacea
![Page 55: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/55.jpg)
Papulopustular rosacea
![Page 56: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/56.jpg)
Rhinophyma
![Page 57: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/57.jpg)
Granulomatous rosacea
![Page 58: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/58.jpg)
Demodex folliculorum residing in hair follicle
![Page 59: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/59.jpg)
Histopathology of rosacea
• Telangiectasia of superficial blood vessels;
• Perivascular infiltrates of lymphocytes (mild to moderate in intensity) and, sometimes, plasma cells.
• Active pustular lesions show superficial folliculitis.
• Older lesions show granulomatous perifolliculitis.
• Demodex mites are noted (20-50% cases)
![Page 60: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/60.jpg)
Histopathology of rosacea
• Well-circumscribed collections of epithelioid histiocytes, usually peri-infundibular.
• Granulomas surrounded usually by lymphocytes and, sometimes, plasma cells.
• Small collections of neutrophils in some granulomas.• Caseous necrosis may be present within some
granulomas. • Rhinophyma: Sebaceous gland hypertrophy and
scattered follicular plugging.
![Page 61: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/61.jpg)
DDx OF ROSACEA
![Page 62: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/62.jpg)
SubtypeSubtype DDxDDx
Erythemato-Erythemato-telangiectatictelangiectatic
1.1. Chronic actinic damage (dermatoheliosis) in fair-Chronic actinic damage (dermatoheliosis) in fair-skinned individualsskinned individuals
2.2. Seborrheic dermatitis Seborrheic dermatitis 3.3. Cutaneous lupus erythematosusCutaneous lupus erythematosus4.4. Keratosis pilaris rubra faciei Keratosis pilaris rubra faciei 5.5. Contact dermatitis (Allergic or Irritant)Contact dermatitis (Allergic or Irritant)
PapulopustularPapulopustular1.1. Acne vulgarisAcne vulgaris2.2. Seborrheic dermatitisSeborrheic dermatitis3.3. Periorificial dermatitis Periorificial dermatitis 4.4. Steroid-induced rosacea. Steroid-induced rosacea. 5.5. Demodex folliculitis.Demodex folliculitis.
PhymatousPhymatous 1.1. Lupus pernio Lupus pernio 2.2. Lupus vulgarisLupus vulgaris
OcularOcular1.1. Seborrheic dermatitis Seborrheic dermatitis 2.2. Allergic contact dermatitis.Allergic contact dermatitis.3.3. Periocular dermatitis Periocular dermatitis
DDx OF ROSACEA
![Page 63: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/63.jpg)
Dermatoheliosis
![Page 64: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/64.jpg)
Seborrheic dermatitis
![Page 65: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/65.jpg)
Malar flush
![Page 66: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/66.jpg)
Keratosis pilaris rubra faciei Keratosis pilaris rubra faciei
![Page 67: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/67.jpg)
Contact dermatitis Contact dermatitis
![Page 68: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/68.jpg)
ROSACEA VS. ACNE
ROSACEA ROSACEA ACNEACNE
ADULTSPAPULESPUSTULESNO COMEDONESERYTHEMATELANGIECTASIAS
TEENSPAPULESPUSTULESCOMEDONESNO ERYTHEMANO TELANGIECTASIAS
![Page 69: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/69.jpg)
Steroid rosacea
![Page 70: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/70.jpg)
Demodex folliculitis.Demodex folliculitis.
![Page 71: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/71.jpg)
Lupus Pernio
![Page 72: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/72.jpg)
Lupus Vulgaris
![Page 73: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/73.jpg)
TREATMENT OF ROSACEA
![Page 74: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/74.jpg)
![Page 75: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/75.jpg)
Treatment of rosacea
![Page 76: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/76.jpg)
Treatment of rosacea• On 2013, FDA approved
brimonidine (Mirvaso®) topical gel, 0.33% for the (first and only) topical treatment of persistent facial erythema of rosacea in adults 18 years of age or older.
• It is not indicated for the treatment of inflammatory lesions (papules and pustules) of rosacea.
• It is selective alpha-2 adrenergic agonist causing cutaneous vasoconstriction.
![Page 77: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/77.jpg)
Treatment of rosacea
![Page 78: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/78.jpg)
![Page 79: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/79.jpg)
![Page 80: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/80.jpg)
250
![Page 81: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/81.jpg)
![Page 82: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/82.jpg)
![Page 83: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/83.jpg)
Treatment – Cosmetic Repair
![Page 84: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/84.jpg)
Treatment: CO2 laser, one treatment. Heal time was just
over 12 days.
![Page 85: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/85.jpg)
![Page 86: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/86.jpg)
• Avoid precipitating factors.
• Sometimes, successful treatment of the inflammatory lesions of papulopustular rosacea reveals background telangiectasias (the PERT phenomenon – “post-erythema-revealed telangiectasias”)
• Topical and systemic therapies used to treat papulopustular rosacea are often ineffective in the treatment of erythematotelangiectatic rosacea and may irritate the skin.
![Page 87: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/87.jpg)
EXPECTATIONS
• Tell them to expect improvement in 4-6 weeks• Tell them to continue regimen until next visit• May give topicals for maintenance otherwise,
relapse is likely 3 to 6 months after discontinuation of treatment.
• Inform them there is no cure for rosacea!!!!!!!!
![Page 88: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/88.jpg)
LUPUS MILIARIS DISSEMINATUS FACIEI
(LMDF)
![Page 89: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/89.jpg)
LMDF
• Uncommon chronic inflammatory facial dermatosis. It presents with pale papules which may be confused with sarcoid or syringoma clinically.
• Many authors now consider LMDF to be an extreme variant of granulomatous rosacea. Others believe it is a distinct entity because of its characteristic histopathology and occasional involvement of non-central facial areas.
![Page 90: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/90.jpg)
LMDF• Age; Young adults in their 20s most often
are affected.
• Etiology; and pathogenesis are unknown.
• Active disease usually involves a 1- to 3-year course and resolves spontaneously.
• Recurrences are not described.
• LMDF may result in disfiguring scarring.
• Educate patients about the nature of the disease to help alleviate anxiety and to establish realistic treatment expectations.
![Page 91: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/91.jpg)
C/P of LMDF
• Papules singly or in crops that are red, brown, or yellow-brown and appear on the central face, especially on and around the eyelids.
• Lesions occasionally may be generalized and appear on the extremities or trunk
• May present later as crusts, pustules ultimately, scars.
![Page 92: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/92.jpg)
![Page 93: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/93.jpg)
Histopathology of LMDF• In LMDF, sections show
round granulomas composed of epithelioid cells with central caseating necrosis.
• The granulomas may appear sarcoidal or tuberculoid typically arise adjacent to adnexal structures.
• A chronic inflammatory infiltrate often present.
• Late lesions show fibrosis
![Page 94: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/94.jpg)
![Page 95: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/95.jpg)
Treatment of LMDF
• Surgical: Scar revision procedures (laser resurfacing,
dermabrasion, chemical peel) may benefit patients after the disease has run its course.
![Page 96: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/96.jpg)
REFERENCES
• Dan Ladd, D.O. Texas/KCOM Dermatology Residency Program Program Director Bill V. Way, D.O.
• Bolognia 3rd ed.
• http://dermnetnz.org/acne/rosacea.html
• http://emedicine.medscape.com
![Page 97: Rosacea](https://reader037.vdocuments.us/reader037/viewer/2022110307/556b1bbad8b42adb338b4a63/html5/thumbnails/97.jpg)
THANK YOU